skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

TNF-α inhibitors: are they carcinogenic?

Review

(1541) Views  (460) Full article downloads

Authors: αGirindra Raval, Paulette Mehta

Published Date December 2010 Volume 2010:2 Pages 241 - 247
DOI: http://dx.doi.org/10.2147/DHPS.S7829

Girindra Raval1, Paulette Mehta2,3
1Jefferson Regional Medical Center, Jefferson Hills, PA, USA; 2Department of Internal Medicine (Hematology/Oncology), UAMS, Little Rock, AR, USA; 3Central Arkansas Veterans Healthcare System, Little Rock, AR, USA

Abstract: Biologic therapy has increasingly been used in the treatment of chronic diseases. Tumor necrosis factor (TNF) is a cytokine implicated in the pathogenesis of rheumatoid arthritis and inflammatory bowel disease. Anti-TNF therapy is being used in the treatment of these conditions. Since the introduction of anti-TNF agents, there have been many case reports of development of malignancy after the initiation of anti-TNF therapy. With increasing case reports, there is growing concern that anti-TNF therapy, albeit useful in the treatment of these chronic conditions, might be associated with the development of malignancy in patients. In this review we examine the different anti-TNF agents and different studies to evaluate any possible association between use of any anti-TNF agent and development of malignancy.

Keywords: tumor necrosis factor inhibitor, malignancy, rheumatoid arthritis, inflammatory bowel disease






Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio